The protease inhibitor leupeptin was shown to inhibit retrovirus infection in mouse fibroblasts at a step shortly after internalization of the virus particles. The inhibited step most likely was the passage of virus particles through the lysosomes or other acid vesicles. Leupeptin was also shown to inhibit degradation of virus particles in the lysosomes. The results are discussed with respect to the involvement of proteases in the infectious route.
We have previously proposed that retrovirus enters cultured mouse fibroblasts through the lysosomes or other intracellular acid vesicles of the cell (1). Entry to the cytoplasm from the vesicles is believed to occur by low-pH-dependent membrane fusion between the virus and the vesicle membranes (13) . However, not all virus particles enter the cytoplasm; one-third or more are degraded in the lysosomes into trichloroacetic acid (TCA)-soluble material, which rapidly is excreted into the media (1). Both virus infection and degradation are inhibited by lysosomotropic bases (1), which raise the pH in acid vesicles of the cell (3) . Infection is believed to be inhibited because of its low-pH-dependent step (1, 13), and degradation is believed to be inhibited because the lysosomal proteases have acid optima (4) . Degradation and membrane fusion appear to be two parallel pathways, which conceivably are competing. However, it is not known whether a limited proteolytic cleavage of the virus particle is necessary for infection. We have tested this by using the protease inhibitor leupeptin. Leupeptin inhibits lysosomal protein degradation to a large extent and nonlysosomal protein degradation to a lesser extent (4, 10) by inhibiting specific proteases. We found that leupeptin inhibited both virus degradation and infection.
Retrovirus C57MC pool 1636 and mouse fibroblast lines SC-1 and BALB 3T3 were used. Culture conditions, radioactive labeling of virus, assays for infection, and other methods have previously been described in detail (1). Leupeptin was obtained from Sigma Chemical Co., St. Louis, Mo., both as the natural compound from Streptomyces roseus and as the synthetic com-
Leupeptin did not interfere with the growth of the cells (see Table 1 ) and did not cause vacuolation of the cells, as the lysosomotropic bases do (3) , indicating that the lysosomal pH was unaltered. (4, 10) . The inhibition of degradation was examined further (Fig. 2) . Degradation starts 1 to 2 h after virus addition and terminates after ca. 20 h (see reference 1). When leupeptin was added, degradation did occur, but the initial rate was lower than it was in the control; however, the degrada- Effect of leupeptin on binding, internalization, and degradation of 3H-labeled C57MC virus in BALB 3T3 cells. Leupeptin was added at the indicated concentrations to 2-cm2 BALB 3T3 cultures. After 2 h 3H-labeled C57MC virus (6,720 cpm) was added to each culture. The cultures were harvested 5 h after virus addition. The media were removed and surface bound (U), and the internal virus material was measured as the radioactivity which was removed or not removed with 0.25% trypsin-1 mM EDTA in phosphate-buffered saline for 25 min at 0°C (1). The trypsinresistant material was then precipitated with 8% TCA for 1 h at 0°C. The total internal (0) and the TCAsoluble internal (0) radioactivities are shown. Degraded virus material (A) was measured as the radioactivity in the media which was soluble after precipitation with 8% TCA for 1 h at 0°C (1). The TCA-soluble radioactivity of the virus preparation (1.5%) was subtracted from the latter results. Values are presented as percentages of added radioactivity, and the bars indicate the standard deviations of four determinations. tion proceeded for longer time than it did in the control. Thus, the degree of degradation when leupeptin was added in comparison with that in the control reached 17% after 4 h, 47% after 23 h, and 63% after 48 h (Fig. 2) .
Leupeptin was added or removed 3 h after virus addition to examine how rapidly it acts (Fig. 2) . Leupeptin inhibited virus degradation in less than 0.5 h after its addition. The inhibition was released within ca. 2 h after leupeptin removal, and after 20 h the level of degradation was almost as great as it was in the control without leupeptin. Leupeptin thus rapidly reaches the lysosomes, but its effect there only slowly vanishes. Thus, in one experiment (data not shown) leupeptin was washed away 1.5 h before virus addition, and some inhibition of virus degradation was observed.
The result that degradation in inhibited cultures can reach virtually the same level as degradation in cultures without leupeptin shows that the majority of the internally accumulated virus material is susceptible to degradation. The internally accumulated virus material must therefore be located in the lysosomes or at a step preceding entry into the lysosomes.
The effect of leupeptin on the life cycle of retrovirus was examined (Fig. 3) . It did not inhibit the production of retrovirus from preinfected cells. Occasionally, even an increased amount of retrovirus was observed. The de novo infection was examined by measuring both the produced viral protein p30 in the cells (8) and the produced virus particles (pelletable reverse transcriptase in the media [9] ). The de novo infection was inhibited by leupeptin, as measured by both methods. Inhibition of the infection was seen in two types of mouse fibroblasts, SC-1 and BALB 3T3. Natural leupeptin was used in these experiments; synthetic leupeptin has been tested and gave identical results (data not shown). The concentration causing 50% inhibition was 10 to 30 p.g/ml, which is similar to the concentration giving half-maximal inhibition of degradation. The degree of inhibition of infection differed among experiments; thus, full infection was not always observed at 300 jig/ml. Because the Fig. 1 ) of media harvested at the indicated times. After the 3-h period, 12,700 -+-600 cpm was bound or had been bound (degraded material). Results are presented as percentages of the radioactivity which was bound or had been bound after the 3-h period. Symbols: *, no leupeptin added; A, 100 Fg of leupeptin per ml added 2 h before virus addition; H, 100 ,ug leupeptin per ml added 3 h after virus addition; o, 100 ng of leupeptin per ml added 2 h before and removed 3 h after virus addition. The TCA-soluble radioactivity in the virus preparation (3.5%) was subtracted from the results. production of virus particles from preinfected cells was not inhibited, it is concluded that the viral life cycle was inhibited after the virus particle was present in the media and before its genome was integrated into the cell nucleus.
The step(s) inhibited by leupeptin was characterized further (Table 1) . Cellular DNA and protein synthesis were not affected by leupeptin, except slightly at 1,000 ,ug/ml. Leupeptin also did not interfere with infection when leupeptin was present only before virus addition. When virus was incubated with leupeptin, diluted (to lower the leupeptin concentration), and added to cell cultures, no inhibition of the subsequent infection was observed, showing that leupeptin does not destroy the virus particles. The inhibition must therefore occur at a step during entry. Binding of virus particles occurs at 0°C, whereas internalization needs higher temperatures to proceed (1). When leupeptin was present at a binding period at 0°C followed by washing and incubation of the cells at 37°C, no inhibition was observed. Physical particles have been shown to be representative of infectious particles with Fresh media and leupeptin were added to BALB 3T3, SC-1, and preinfected SC-1 cultures. The media from the preinfected SC-1 cultures (0) were harvested after 1 day, and the amount of pelletable reverse transcriptase was measured (9) and expressed as the percentage of controls not receiving leupeptin, which measured 241,000 + 25,000 cpm in the assay. At 1 h after leupeptin addition, 2,500 PFU of C57MC virus was added to 2-cm2 BALB 3T3 (A) and SC-1 (0) cultures. The media were harvested after 2 days, and the pelletable reverse transcriptase was measured. The BALB 3T3 and SC-1 control cultures measured 92,000 + 13,000 and 17,000 ± 4,000 cpm, respectively. At 1 h after leupeptin addition, 250 PFU was added to 20-cm2 BALB 3T3 cultures (U). The cultures were fixed with methanol after 2 days and immunostained for production of p30 (8) . The control cultures showed 257 ± 47 plaques. The data points represent the averages of at least two determinations.
respect to binding and internalization (1). The results shown in Fig. 1 are then in agreement with the lack of inhibition of binding and, furthermore, show that the infection was not inhibited at the internalization step. Inhibition of infection must then occur after internalization.
The time period of sensitivity to leupeptin was examined (Table 1) . When leupeptin was added immediately after the binding period, the infection was inhibited. When leupeptin was added 1 h after binding, it could still inhibit infection, but when leupeptin was added 5 h after binding, little inhibition was observed. When leupeptin was added 7 or 21 h after binding, no inhibition was observed. Since leupeptin was shown to act in the cells within 0.5 h, the results show that the leupeptin-sensitive step occurred mainly from 1 to 8 h after binding. Reverse transcription of the viral genome begins in this period; however, reverse transcription was not affected by up to 1,000 p.g of leupeptin per ml when assayed in vitro ( Table 1 ), indicating that leupeptin acts before the processing of the viral genome begins. The time period of sensitivity to leupeptin is identical to the period when infection could be inhibited by lysosomotropic bases (1) and to the period when degradation occurs (Fig. 2 and reference 1). Degradation was, furthermore, inhibited at the same leupeptin concentrations. In summary, the results strongly suggest that leupeptin inhibits infection at a step in the lysosomes. Leupeptin does, however, inhibit nonlysosomal proteases (4, 10) , so the possibility cannot be excluded that it inhibits infection at a step shortly after entry into the cytoplasm.
Leupeptin is an inhibitor of several serine and thiol proteases, including the lysosomal protease cathepsin B (2). Other lysosomal proteases, e.g., the carboxyl protease cathepsin D, are not inhibited by leupeptin. This selective inhibition of lysosomal proteases can explain why degradation of virus particles was not totally inhibited by leupeptin. Degradation proceeded but at a decreased rate, and the virus particles awaiting degradation to TCA solubility appeared to be accumulated in the lysosomes or at another step preceding degradation.
Infection and degradation seem to be competing reactions. It is therefore interesting that a protease inhibitor can inhibit infection. However, it can be speculated that proteolytic cleavage of the virus surface proteins is important for membrane fusion to occur. It is thus possible that a fine balance between partial and full degradation is necessary for successful infection and that this balance is disturbed by leupeptin.
In the case of influenza virus, it has been shown that specific posttranslational cleavage of the surface protein, the hemagglutinin precursor HAO, into the subunits HAl and HA2 is essen- (9) . Each value represents the average of at least four determinations. The effect of leupeptin on the activity of the reverse transcriptase was tested when leupeptin was added directly to the reverse transcriptase assay. Media from infected cultures were then used as a source of reverse transcriptase. tial for membrane fusion to occur (12) . This functional cleavage can be obtained in vitro by a brief treatment with trypsin. Since leupeptin seems to inhibit proteases with trypsin-like activity (cleavage next to arginine and lysine) (2, 6), it is plausible that a similar specific cleavage, although occurring during entry, is necessary for retrovirus infection. Inhibition of virus degradation and infection has also been observed with the protease inhibitor antipain (unpublished data), which resembles leupeptin in structure and specificity (2).
Leupeptin has been shown to inhibit chemical 
